MedPath

Oxytocin Dosing at Planned Cesarean Section and Anemia

Phase 4
Withdrawn
Conditions
Blood Loss Anemia
Uterine Atony With Hemorrhage
Interventions
Registration Number
NCT03361124
Lead Sponsor
Milton S. Hershey Medical Center
Brief Summary

Patient's with planned cesarean sections will be randomized to receive either standard 20 mU in 1L as a bolus following delivery of the placenta or 20 mu in 1L following delivery of the placenta plus an additional 20 mU in 1L over 8 hours.

Detailed Description

The purpose of this study is to examine the impact of differential dose protocols commonly utilized in the post cesarean period to determine if laboratory definitions of anemia are different. Oxytocin is an antidiuretic hormone that is utilized after delivery of the fetus and placenta to contract the uterus and decrease blood loss both at the time of surgery and in the post-partum period. Here at the Penn State Hershey Medical center the investigators will use 20 units of oxytocin in a 1 L bag of LR in bolus fashion after delivery of the placenta. Other protocols use an extended course of therapy using 20 units of oxytocin in a 1 L bag of LR in a bolus plus an additional 20 units of oxytocin in a 1 L bag of LR over an 8 hour period of time.

We hypothesize that:

* Women who receive the standard 20 mU of oxytocin in 1L of LR in bolus fashion plus 20 mU in 1L over 8 hours will have a decreased reduction in pre-operative vs post-operative hematocrit and hemoglobin versus those that receive 20 mU in 1L of LR.

* Women who receive the standard 20 mU of oxytocin in 1L of LR in bolus fashion plus 20 mU in 1L over 8 hours will have decreased blood loss by weight in the postpartum period compared to patients who receive 20 mU in 1L of LR.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Planned cesarean sections for singletons at or greater than 37 weeks gestational age
  • Primary or repeat cesarean section will be included
Exclusion Criteria
  • Multiple fetal pregnancies
  • Hematologic disorders
  • Fetal anomalies
  • Pre-eclampsia. These patients are at increased risk of fluid overload and so fluid status may be affected by receiving a second bag of fluid containing oxytocin in the postpartum period.
  • Known contraindication to oxytocin
  • Hypersensitivity to oxytocin
  • Patients who have labored and then proceed with cesarean section for any reason. Patients who have labored have had either intrinsic or extrinsic exposure to oxytocin. These patients may have decreased sensitivity to oxytocin.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlOxytocinPatient will receive standard post-partum Oxytocin (20 mU in 1 L LR) and 1 L LR over 8 hours following delivery.
TreatmentOxytocinPatient will receive standard post-partum Oxytocin(20 mU in 1 L LR) an additional 20 mU Oxytocin in 1 L LR over 8 hours following delivery.
Primary Outcome Measures
NameTimeMethod
Blood loss in postpartum period defined by grams/hour3-4 days after delivery

Measure pads used post-partum

Secondary Outcome Measures
NameTimeMethod
Edinburgh post-partum depression scale >106 weeks

Did the patient score greater than 10 points on Edinburgh post-partum depression scale?

Change in Hemoglobin24 hours

Pre-op hemoglobin and post-op hemoglobin

Need for additional uterotonics24 hours after delivery

Use of uterotonics

Quantity of narcotic pain medications3-4 days after delivery

Number of narcotic tablets used from time of surgery to discharge

Attendance at post-partum visit6 weeks

Did patient attend post-partum visit?

Post-partum complications6 weeks

Did patient have surgical wound infection, endometritis?

Change in Hematocrit24 hours

Pre-op hematocrit and post-op hematocrit

Length of hospital stay3-4 days after delivery

Start of surgery to discharge (hours)

Continuation of breastfeeding6 weeks

Is patient breastfeeding at 6 week post-partum visit

Need for blood transfusion3-4 days after delivery

Did the patient require blood transfusion?

© Copyright 2025. All Rights Reserved by MedPath